For research use only. Not for therapeutic Use.
Enzaplatovir（Cat No.:I006680）is a potent antiviral agent primarily studied for its activity against respiratory syncytial virus (RSV). This small-molecule inhibitor targets the RSV replication complex, disrupting viral RNA synthesis and replication. Enzaplatovir has shown promise in preclinical and clinical investigations for its efficacy in reducing viral load and alleviating symptoms of RSV infection. Its well-defined mechanism of action and pharmacokinetics make it an essential compound for virology research. Enzaplatovir supports the development of novel therapeutics for RSV, addressing a significant unmet need in respiratory infectious disease management.
| Catalog Number | I006680 |
| CAS Number | 1323077-89-9 |
| Synonyms | Enzaplatovir;BTA-585; BTA585; BTA 585; BTA-C585; BTAC585; BTA C585;(R)-1-(3-methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2,3,10,10a-tetrahydro-1H,5H-imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one |
| Molecular Formula | C20H19N5O3 |
| Purity | ≥95% |
| Target | RSV |
| Solubility | Soluble in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | (3R)-4-(3-methyl-1,2-oxazole-4-carbonyl)-3-(6-methylpyridin-3-yl)-1,4,7-triazatricyclo[7.3.0.03,7]dodeca-9,11-dien-8-one |
| InChI | InChI=1S/C20H19N5O3/c1-13-5-6-15(10-21-13)20-12-23-7-3-4-17(23)19(27)25(20)9-8-24(20)18(26)16-11-28-22-14(16)2/h3-7,10-11H,8-9,12H2,1-2H3/t20-/m0/s1 |
| InChIKey | KUDXTBCRESIJFH-FQEVSTJZSA-N |
| SMILES | CC1=NC=C(C=C1)[C@]23CN4C=CC=C4C(=O)N2CCN3C(=O)C5=CON=C5C |
